EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 62 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $403,454 | -54.9% | 46,374 | +7.2% | 0.00% | 0.0% |
| Q1 2024 | $894,494 | +780.3% | 43,275 | +884.2% | 0.00% | – |
| Q4 2023 | $101,615 | +120.1% | 4,397 | -23.9% | 0.00% | – |
| Q3 2023 | $46,174 | -39.1% | 5,779 | -33.7% | 0.00% | – |
| Q2 2023 | $75,803 | +165.8% | 8,713 | -10.2% | 0.00% | – |
| Q1 2023 | $28,515 | -21.8% | 9,699 | -6.9% | 0.00% | – |
| Q4 2022 | $36,449 | -55.0% | 10,414 | +1.1% | 0.00% | – |
| Q3 2022 | $81,000 | -8.0% | 10,297 | -7.7% | 0.00% | – |
| Q2 2022 | $88,000 | -32.3% | 11,155 | +4.3% | 0.00% | – |
| Q1 2022 | $130,000 | -7.1% | 10,691 | -6.3% | 0.00% | – |
| Q4 2021 | $140,000 | +17.6% | 11,408 | 0.0% | 0.00% | – |
| Q3 2021 | $119,000 | -54.6% | 11,408 | -60.9% | 0.00% | – |
| Q2 2021 | $262,000 | – | 29,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,551,521 | $13,498,233 | 4.40% |
| Cormorant Asset Management, LP | 8,325,000 | $72,427,500 | 4.18% |
| ORACLE INVESTMENT MANAGEMENT INC | 231,857 | $2,017,156 | 1.88% |
| Finepoint Capital LP | 707,404 | $6,154,415 | 1.75% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,175,823 | $45,029,660 | 1.65% |
| Octagon Capital Advisors LP | 1,093,503 | $9,513,476 | 1.50% |
| TCG Crossover Management, LLC | 922,335 | $8,024,315 | 0.84% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 37,838 | $329,191 | 0.42% |
| Corton Capital Inc. | 49,905 | $434,174 | 0.23% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $870,000 | 0.20% |